Clinical Trial: Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915570) titled 'Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers' on Oct. 15.

Brief Summary: The goal of this observational study is to learn whether two inflammatory proteins, interleukin-8 (IL-8) measured in saliva and interleukin-6 (IL-6) measured in blood serum, can help distinguish adults with oral potentially malignant disorders (OPMDs), such as oral lichen planus and leukoplakia, from adults with healthy oral mucosa, and whether smoking changes these protein levels.

The main questions it aims to answer are:

* Do salivary IL-8 and serum IL-6 levels differ between people with OPM...